Prebiotic, probiotic, and chlorophyllin interventions differentially attenuate melphalan-induced intestinal injury and modulate gut metabolite profiles
4 affiliations
- 1Department of Clinical Pharmacology, ACTREC, Tata Memorial Centre
- 2Bioinformatics and Computational Biology, Cancer Research Institute, ACTREC, Tata Memorial Centre
- 3Department of Digital & Computational Oncology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre
- 4Homi Bhabha National Institute
Abstract
Introduction: Melphalan treatment can cause substantial gastrointestinal toxicity, yet the relationship between chemotherapy-induced epithelial injury, intestinal barrier dysfunction, and alterations in the gut metabolic environment remains incompletely understood. Here, we investigated whether nutritionally and mechanistically distinct interventions could attenuate melphalan-induced intestinal injury and associated metabolic perturbations.
Methods: C57BL/6 mice were allocated to vehicle control, melphalan alone, melphalan plus fructo-oligosaccharides (FOS), melphalan plus a commercial probiotic preparation containing Lacticaseibacillus paracasei Shirota, or melphalan plus chlorophyllin ( n = per group). Interventions were administered orally for 3 days before and 3 days after a single oral dose of melphalan (10 mg/kg). Intestinal toxicity was characterized through physiological outcomes, circulating markers of epithelial injury and barrier dysfunction, intestinal protein expression, and targeted LC–MS/MS profiling of short-chain fatty acids, bile acids, and indole-derived metabolites.
Results: Melphalan induced body-weight loss and shortening of the small intestine, accompanied by reduced plasma citrulline and increased circulating lipopolysaccharide and occludin, consistent with enterocyte loss and impaired intestinal barrier integrity. These alterations coincided with broad reductions across multiple metabolite classes, indicating substantial disruption of the intestinal metabolic environment. FOS, the commercial probiotic preparation, and chlorophyllin attenuated body-weight loss and restored small-intestinal length and plasma-marker levels toward vehicle-control values. FOS and the probiotic preparation significantly increased selected SCFAs and bile acids, whereas the probiotic preparation and chlorophyllin significantly increased selected tryptophan-derived metabolites. Chlorophyllin also significantly increased taurocholate relative to melphalan alone.
Discussion: These findings support further investigation of gut-directed nutritional interventions as strategies to mitigate chemotherapy-associated intestinal injury, with the exploratory metabolite findings requiring confirmation in larger studies.
Related
- Oral inulin prebiotic encapsulating Cortex Fraxini extracellular vesicles alleviates colitis and associated renal stress via reinforcing intestinal barriers and remodeling microbiota.
- Hox gene activity directs physical forces to differentially shape chick small and large intestinal epithelia
- Polarized macrophage-derived microvesicles differentially modulate intestinal barrier dysfunction and endoplasmic reticulum stress in ulcerative colitis.
- High-pressure processing and thermal pasteurization of blueberry purée-based baby food differentially modulate polyphenol bioaccessibility and intestinal cell responses
- Metabolic Dysregulation and Metabolite-Targeted Interventions in Autism Spectrum Disorder: Mechanisms and Translational Perspectives
BibTeX
@article{redhu2026prebiotic,
title = {{Prebiotic, probiotic, and chlorophyllin interventions differentially attenuate melphalan-induced intestinal injury and modulate gut metabolite profiles}},
author = {Archana Kumari Redhu and Saithang Puia and Nitesh Chavan and Rozma Ali and Abhishek Das and Kshitij Kodolikar and Gourab Das and Sayali Kadam and Kavita Pal and Vikram Gota},
journal = {Frontiers in Microbiology},
year = {2026},
month = oct,
doi = {10.3389/fmicb.2026.2003316},
url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.2003316/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Prebiotic, probiotic, and chlorophyllin interventions differentially attenuate melphalan-induced intestinal injury and modulate gut metabolite profiles
AU - Archana Kumari Redhu
AU - Saithang Puia
AU - Nitesh Chavan
AU - Rozma Ali
AU - Abhishek Das
AU - Kshitij Kodolikar
AU - Gourab Das
AU - Sayali Kadam
AU - Kavita Pal
AU - Vikram Gota
PY - 2026
DA - 2026/10/29
JO - Frontiers in Microbiology
DO - 10.3389/fmicb.2026.2003316
UR - https://www.frontiersin.org/articles/10.3389/fmicb.2026.2003316/full
AB - Introduction: Melphalan treatment can cause substantial gastrointestinal toxicity, yet the relationship between chemotherapy-induced epithelial injury, intestinal barrier dysfunction, and alterations in the gut metabolic environment remains incompletely understood. Here, we investigated whether nutritionally and mechanistically distinct interventions could attenuate melphalan-induced intestinal injury and associated metabolic perturbations. Methods: C57BL/6 mice were allocated to vehicle control, melphalan alone, melphalan plus fructo-oligosaccharides (FOS), melphalan plus a commercial probiotic preparation containing Lacticaseibacillus paracasei Shirota, or melphalan plus chlorophyllin ( n = per group). Interventions were administered orally for 3 days before and 3 days after a single oral dose of melphalan (10 mg/kg). Intestinal toxicity was characterized through physiological outcomes, circulating markers of epithelial injury and barrier dysfunction, intestinal protein expression, and targeted LC–MS/MS profiling of short-chain fatty acids, bile acids, and indole-derived metabolites. Results: Melphalan induced body-weight loss and shortening of the small intestine, accompanied by reduced plasma citrulline and increased circulating lipopolysaccharide and occludin, consistent with enterocyte loss and impaired intestinal barrier integrity. These alterations coincided with broad reductions across multiple metabolite classes, indicating substantial disruption of the intestinal metabolic environment. FOS, the commercial probiotic preparation, and chlorophyllin attenuated body-weight loss and restored small-intestinal length and plasma-marker levels toward vehicle-control values. FOS and the probiotic preparation significantly increased selected SCFAs and bile acids, whereas the probiotic preparation and chlorophyllin significantly increased selected tryptophan-derived metabolites. Chlorophyllin also significantly increased taurocholate relative to melphalan alone. Discussion: These findings support further investigation of gut-directed nutritional interventions as strategies to mitigate chemotherapy-associated intestinal injury, with the exploratory metabolite findings requiring confirmation in larger studies.
SN - 1664-302X
ER -